All Stories

  1. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2016, Dove Medical Press

    Alan Hamilton, François Maltais, Louise Auclair

  2. Pharmacokinetics and safety of olodaterol administered with the Respimat Soft Mist inhaler in subjects with impaired hepatic or renal function

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2016, Dove Medical Press

    atef halabi, Alan Hamilton

  3. The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and luticasone propionate via Accuhaler® (ENERGITO® study)

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2016, Dove Medical Press

    Dr Dongmei Zhai, Alan Hamilton

  4. Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2015, Dove Medical Press

    Professor Yoshinosuke Fukuchi, Alan Hamilton

  5. Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2014, Taylor & Francis

    Prof. Pierluigi Paggiaro, Alan Hamilton

  6. Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2014, Dove Medical Press

    Alan Hamilton

  7. Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2014, Taylor & Francis

    Alan Hamilton

  8. Assessing patient report of function: content validity of the Functional Performance Inventory-Short Form (FPI-SF) in patients with chronic obstructive pulmonary disease (COPD)

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2012, Taylor & Francis

    Alan Hamilton